A detailed history of Stephens Consulting, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Stephens Consulting, LLC holds 2,086 shares of NVO stock, worth $297,755. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,086
Previous 86 2325.58%
Holding current value
$297,755
Previous $8.9 Million 2910.49%
% of portfolio
0.08%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

BUY
$102.11 - $135.92 $204,220 - $271,840
2,000 Added 2325.58%
2,086 $268 Million
Q3 2023

Oct 25, 2023

BUY
$90.94 - $199.54 $3,910 - $8,580
43 Added 100.0%
86 $7.82 Million
Q4 2022

Jan 19, 2023

SELL
$102.55 - $135.33 $4,922 - $6,495
-48 Reduced 52.75%
43 $5.82 Million
Q4 2021

Jan 19, 2023

BUY
$95.88 - $117.08 $8,725 - $10,654
91 New
91 $10.2 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $322B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Stephens Consulting, LLC Portfolio

Follow Stephens Consulting, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stephens Consulting, LLC with notifications on news.